Cargando…

Targeting mesothelin in ovarian cancer

Detalles Bibliográficos
Autores principales: Ghafoor, Azam, Thomas, Anish, Hassan, Raffit
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6281414/
https://www.ncbi.nlm.nih.gov/pubmed/30546824
http://dx.doi.org/10.18632/oncotarget.26350
_version_ 1783378824769044480
author Ghafoor, Azam
Thomas, Anish
Hassan, Raffit
author_facet Ghafoor, Azam
Thomas, Anish
Hassan, Raffit
author_sort Ghafoor, Azam
collection PubMed
description
format Online
Article
Text
id pubmed-6281414
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Impact Journals LLC
record_format MEDLINE/PubMed
spelling pubmed-62814142018-12-13 Targeting mesothelin in ovarian cancer Ghafoor, Azam Thomas, Anish Hassan, Raffit Oncotarget News Impact Journals LLC 2018-11-16 /pmc/articles/PMC6281414/ /pubmed/30546824 http://dx.doi.org/10.18632/oncotarget.26350 Text en Copyright: © 2018 Ghafoor et al. http://creativecommons.org/licenses/by/3.0/ This article is distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0/) (CC-BY), which permits unrestricted use and redistribution provided that the original author and source are credited.
spellingShingle News
Ghafoor, Azam
Thomas, Anish
Hassan, Raffit
Targeting mesothelin in ovarian cancer
title Targeting mesothelin in ovarian cancer
title_full Targeting mesothelin in ovarian cancer
title_fullStr Targeting mesothelin in ovarian cancer
title_full_unstemmed Targeting mesothelin in ovarian cancer
title_short Targeting mesothelin in ovarian cancer
title_sort targeting mesothelin in ovarian cancer
topic News
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6281414/
https://www.ncbi.nlm.nih.gov/pubmed/30546824
http://dx.doi.org/10.18632/oncotarget.26350
work_keys_str_mv AT ghafoorazam targetingmesothelininovariancancer
AT thomasanish targetingmesothelininovariancancer
AT hassanraffit targetingmesothelininovariancancer